1: NIAGARA Study is the Forefront of Post-ASCO GU Discussion in Bladder Cancer

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/ef/2b/a5/ef2ba566-14c5-0829-65e4-66b8116de434/mza_10513040257090650742.png/600x600bb.jpg

Oncology Decoded

18 episodes

3 weeks ago

Experts highlight the top 5 presentations from ESMO 2025 that may have long-term clinical implications for genitourinary cancer management.

Science

RSS

All content for Oncology Decoded is the property of Oncology Decoded and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Experts highlight the top 5 presentations from ESMO 2025 that may have long-term clinical implications for genitourinary cancer management.

Science

1: NIAGARA Study is the Forefront of Post-ASCO GU Discussion in Bladder Cancer

Oncology Decoded

33 minutes

8 months ago

1: NIAGARA Study is the Forefront of Post-ASCO GU Discussion in Bladder Cancer